TNFSF11 and lung cancer: Li-Mien Chen et al. studied the role of the RANKL/RANK axis in human lung cancer (A549) cells, discovering its ability to activate ICAM-1 and enhance tumor migration, a process that could be inhibited by PDTC, a NF-κB pathway inhibitor [30].